MoneyWorks4Me

Dr. Reddys Laboratories inform about press release

19 Mar 2020 Evaluate

Dr. Reddys Laboratories has informed that the company has enclosed a Press Release on March 19 2020 tilted ‘Dr. Reddy's Laboratories announces first-to-market launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Singledose Prefilled Syringe in the US Market.’

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..